Vital Signsby BridgeheadAll voices

01  Voice · Academic · Heart disease & stroke

Vinicius de Sousa Barzon Serra: no photograph is held, so the academic plate is shown instead.
Academic

Vinicius de Sousa Barzon Serra

Study leader, Mayo Clinic in Scottsdale, Arizona

Press citations per month · linked articles
1
Nov 2026to date
1

press citation on 1 topic since 4 Nov 2026 · last quoted 4 Nov 2026

02  Quoted on · 1 of 29 topics

Open the topic

Vinicius de Sousa Barzon Serra: key facts

Kind of voice
Academic
Role
Study leader, Mayo Clinic in Scottsdale, Arizona
Tracked press citations
1
Most recently quoted
4 Nov 2026

04  On the record · press

What Vinicius de Sousa Barzon Serra has said

By outlet · linked articles
  • reuters.com1

Where Vinicius de Sousa Barzon Serra has been quoted

  1. 01NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicinereuters.com · 4 Nov 2026

Verbatim

“This research may add to the case for considering GLP-1 medications earlier for certain patients, rather than waiting until they develop type 2 diabetes.”
Study leader, Mayo Clinic in Scottsdale, Arizona · Heart disease & stroke · reuters.com · 4 Nov 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.